The clinical significance of soluble E-cadherin in nonsmall cell lung cancer

Aim: Aberrant expression of the epithelial transmembrane adhesion molecule E-cadherin (E-cad) has been associated with many human malignancies. In the present study the clinical significance of serum levels of soluble E-cadherin (sE-cad) in newly diagnosed patients with non small cell lung cancer (N...

Full description

Saved in:
Bibliographic Details
Date:2006
Main Authors: Charalabopoulos, K., Gogali, A., Dalavaga, Y., Daskalopoulos, G., Vassiliou, M., Bablekos, G., Karakosta, A., Constantopoulos, S.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2006
Series:Experimental Oncology
Subjects:
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/137548
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:The clinical significance of soluble E-cadherin in nonsmall cell lung cancer / K. Charalabopoulos, A. Gogali, Y. Dalavaga, G. Daskalopoulos, M. Vassiliou, G. Bablekos, A. Karakosta, S. Constantopoulos // Experimental Oncology. — 2006. — Т. 28, № 1. — С. 83-85. — Бібліогр.: 24 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
Description
Summary:Aim: Aberrant expression of the epithelial transmembrane adhesion molecule E-cadherin (E-cad) has been associated with many human malignancies. In the present study the clinical significance of serum levels of soluble E-cadherin (sE-cad) in newly diagnosed patients with non small cell lung cancer (NSCLC) was investigated. Material and Methods: An enzyme linked immunospecific assay (ELISA) to determine the circulating levels of sE-cad in 20 newly diagnosed patients with NSCLC as well as in 29 healthy volunteers (control group) was used. Results: NSCLC patients exerted increased circulating levels of sE-cad compared with individuals of the control group (p < 0.001). An association was also detected between serum sE-cad levels and the development of distant metastases. On the contrary, no statistically significant correlation could be established with histological type, gender and smoking habits. Patients with increased sE-cad levels at diagnosis had worser outcome, although multivariate analysis failed to demonstrate that sE-cad levels represent an independent prognostic factor of survival. Conclusion: Our data suggest that E-cad plays a role in the pathogenesis of NSCLC. sE-cad levels may be further studied as a potential prognostic biomarker.